Glaxosmithkline Share News (GSK)

EXTRA: GlaxoSmithKline Holds Guidance As Weak Pound Boosts Revenue

TOP NEWS: GlaxoSmithKline Maintains Guidance As Sales Increase

GlaxoSmithKline enjoys big windfall as pound slides

LONDON, Oct 26 (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday it expected even bigger profit gains in 2016 thanks to a weak pound, which has continued to fall after Britain's vote in June to leave the European Union, as quarterly results beat expectations. GSK, which is in the mid

UK fraud head expects corporate plea deals, considers Libor charges

* SFO head David Green gives evidence to UK lawmakers * Green says "significant" new DPAs on horizon * Green says Serco probe looking at "different conduct" By Kirstin Ridley LONDON, Oct 25 (Reuters) - The UK Serious Fraud Office (SFO) expects to agree some "significant" c

UPDATE 1-GSK files potential $1 bln shingles vaccine for U.S. approval

* GSK's Shingrix has outperformed Merck's Zostavax in trials * Consensus forecasts point to $1.05 billion sales in 2021 (Adds sales forecast, background on rival vaccines) By Ben Hirschler LONDON, Oct 24 (Reuters) - GlaxoSmithKline has filed its shingles vaccine Shingrix for U

GSK submits shingles vaccine for US regulatory approval

(ShareCast News) - Pharmaceutical behemoth GlaxoSmithKline announced it has submitted a shingles vaccine for a US regulatory approval. Shingrix, a non-live recombinant vaccine, which prevents herpes zoster, or shingles, in people aged 50 years or over, was submitted to the US Food and Drug Admini

GSK seeks U.S. approval for shingles vaccine Shingrix

LONDON, Oct 24 (Reuters) - GlaxoSmithKline said on Monday it had filed its shingles vaccine Shingrix for U.S. regulatory approval, bringing the potential blockbuster a step closer to market. Shingrix is viewed by analysts as among the British drugmaker's most promising experimental products

TOP NEWS: GlaxoSmithKline Submits Shingles Drug For US Approval

LONDON BRIEFING: NCC, Keller And Senior Drop After Trading Updates

UK Earnings, Trading Statements Calendar - Next 7 Days

WHO seeks new mechanism for crisis vaccine supplies at low cost

By Kate Kelland, Health and Science Correspondent LONDON, Oct 19 (Reuters) - The World Health Organization, drugmakers and humanitarian groups are hammering out details of a new vaccine supply system aimed at getting vital shots to vulnerable people in crises such as wars or natural disaste

Sector movers: Tesco leads cyclicals higher, pharma drags

(ShareCast News) - Cyclicals took over from defensives, with Tesco spearheading gains among food and drug retailers while pharma stocks acted as the main drag. Tesco shares accounted for the lion's share of the gains in that sector after Unilever said issues surrounding the supply of its leading bra

BROKER RATINGS SUMMARY: Investec Starts Wolseley With Hold Rating

Q&A-Pound plunges, stocks up, economy flat: What do Brexit swings mean for you?

By Guy Faulconbridge, Jamie McGeever and David Milliken LONDON, Oct 7 (Reuters) - Sterling has tumbled to a 31-year low, but British stocks are near a record high and, contrary to many expert forecasts, the shock of Brexit has not yet pushed the British economy off a cliff. So what gi

Q&A-Pound down, stocks up, economy flat: What do Brexit swings mean for you?

By Guy Faulconbridge, Jamie McGeever and David Milliken LONDON, Oct 5 (Reuters) - Sterling has tumbled to a 31-year low, but British stocks are near a record high and, contrary to many expert forecasts, the shock of Brexit has not pushed the British economy off a cliff. So what gives?